186 related articles for article (PubMed ID: 21047834)
1. Preventing progression of allergic rhinitis: the role of specific immunotherapy.
Fiocchi A; Fox AT
Arch Dis Child Educ Pract Ed; 2011 Jun; 96(3):91-100. PubMed ID: 21047834
[TBL] [Abstract][Full Text] [Related]
2. Prevention of allergic disease in childhood: clinical and epidemiological aspects of primary and secondary allergy prevention.
Halken S
Pediatr Allergy Immunol; 2004 Jun; 15 Suppl 16():4-5, 9-32. PubMed ID: 15125698
[TBL] [Abstract][Full Text] [Related]
3. [Preventive immunotherapy].
Boquete M; Carballada F; Expósito F; González A
Allergol Immunopathol (Madr); 2000; 28(3):89-93. PubMed ID: 10867376
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of specific immunotherapy in the treatment of allergic rhinitis: an analysis of randomized, prospective, single- or double-blind, placebo-controlled studies.
Ross RN; Nelson HS; Finegold I
Clin Ther; 2000 Mar; 22(3):342-50. PubMed ID: 10963288
[TBL] [Abstract][Full Text] [Related]
5. Pharmacoeconomic assessment of specific immunotherapy versus current symptomatic treatment for allergic rhinitis and asthma in France.
Omnes LF; Bousquet J; Scheinmann P; Neukirch F; Jasso-Mosqueda G; Chicoye A; Champion L; Fadel R
Eur Ann Allergy Clin Immunol; 2007 May; 39(5):148-56. PubMed ID: 17626329
[TBL] [Abstract][Full Text] [Related]
6. The allergic march in pollinosis: natural history and therapeutic implications.
Marogna M; Falagiani P; Bruno M; Massolo A; Riva G
Int Arch Allergy Immunol; 2004 Dec; 135(4):336-42. PubMed ID: 15564776
[TBL] [Abstract][Full Text] [Related]
7. Rhinitis and asthma co-morbidity in respiratory allergy due to house dust mite: results of an observational open controlled parallel group study in real-life setting.
Marogna M; Spadolini I; Massolo A
Eur Ann Allergy Clin Immunol; 2005 Apr; 37(4):135-42. PubMed ID: 15916014
[TBL] [Abstract][Full Text] [Related]
8. National guidelines needed to manage rhinitis and prevent complications.
Rachelefsky GS
Ann Allergy Asthma Immunol; 1999 Mar; 82(3):296-305. PubMed ID: 10094222
[TBL] [Abstract][Full Text] [Related]
9. A randomized, controlled study of specific immunotherapy in monosensitized subjects with seasonal rhinitis: effect on bronchial hyperresponsiveness, sputum inflammatory markers and development of asthma symptoms.
Crimi N; Li Gotti F; Mangano G; Paolino G; Mastruzzo C; Vancheri C; Lisitano N; Polosa R
Ann Ital Med Int; 2004; 19(2):98-108. PubMed ID: 15317270
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of the efficacy of specific immunotherapy with house-dust mite extracts in adults with allergic rhinitis and/or asthma].
Polzehl D; Keck T; Riechelmann H
Laryngorhinootologie; 2003 Apr; 82(4):272-80. PubMed ID: 12717603
[TBL] [Abstract][Full Text] [Related]
11. Allergen-specific immunotherapy in allergic rhinitis and asthma. Mechanisms and proof of efficacy.
Pipet A; Botturi K; Pinot D; Vervloet D; Magnan A
Respir Med; 2009 Jun; 103(6):800-12. PubMed ID: 19216064
[TBL] [Abstract][Full Text] [Related]
12. New visions in specific immunotherapy in children: an iPAC summary and future trends.
Halken S; Lau S; Valovirta E
Pediatr Allergy Immunol; 2008 Aug; 19 Suppl 19():60-70. PubMed ID: 18665964
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of specific immunotherapy with Grazax in allergic rhinitis co-existing with asthma.
Nasser S; Vestenbaek U; Beriot-Mathiot A; Poulsen PB
Allergy; 2008 Dec; 63(12):1624-9. PubMed ID: 19032235
[TBL] [Abstract][Full Text] [Related]
14. Effect of immunotherapy on asthma progression, BHR and sputum eosinophils in allergic rhinitis.
Polosa R; Li Gotti F; Mangano G; Paolino G; Mastruzzo C; Vancheri C; Lisitano N; Crimi N
Allergy; 2004 Nov; 59(11):1224-8. PubMed ID: 15461606
[TBL] [Abstract][Full Text] [Related]
15. How strong is the evidence that immunotherapy in children prevents the progression of allergy and asthma?
Jacobsen L; Valovirta E
Curr Opin Allergy Clin Immunol; 2007 Dec; 7(6):556-60. PubMed ID: 17989534
[TBL] [Abstract][Full Text] [Related]
16. Omalizumab (Xolair) in children with seasonal allergic rhinitis: leukotriene release as a potential in vitro parameter to monitor therapeutic effects.
Kopp MV; Stenglein S; Kamin W; Friedrichs F; von Berg A; Zielen S; Hamelmann E; Wahn U; Kuehr J
Pediatr Allergy Immunol; 2007 Sep; 18(6):523-7. PubMed ID: 17680911
[TBL] [Abstract][Full Text] [Related]
17. Injection and sublingual immunotherapy in the management of allergies affecting the unified airway.
Leatherman B
Otolaryngol Clin North Am; 2008 Apr; 41(2):359-74, vii. PubMed ID: 18328374
[TBL] [Abstract][Full Text] [Related]
18. Grass pollen immunotherapy as an effective therapy for childhood seasonal allergic asthma.
Roberts G; Hurley C; Turcanu V; Lack G
J Allergy Clin Immunol; 2006 Feb; 117(2):263-8. PubMed ID: 16461125
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of the pediatric aspects of the WHO document and meta-analysis of immunotherapy].
Ibáñez Sendín MD
Allergol Immunopathol (Madr); 2000; 28(3):82-9. PubMed ID: 10867375
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of sublingual specific immunotherapy in intermittent and persistent allergic rhinitis in children: an observational case-control study on 171 patients. The EFESO-children multicenter trial.
Acquistapace F; Agostinis F; Castella V; Kantar A; Novembre E; Perrone MR; Pietrasanta M; Sambugaro R; Milani M
Pediatr Allergy Immunol; 2009 Nov; 20(7):660-4. PubMed ID: 19320852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
